Brief: Deep Track Capital Reports 9.99% Passive Stake In Heron Therapeutics
Aug 19 (Reuters) - Heron Therapeutics Inc HRTX.O :
* DEEP TRACK CAPITAL LP REPORTS 9.99% PASSIVE STAKE IN HERON
THERAPEUTICS INC, AS OF AUGUST 9, 2022 - SEC FILING
Source text for Eikon: [https://bit.ly/3wgFDof]
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop